• Prevention of reproductive loss in placental dysfunction

Prevention of reproductive loss in placental dysfunction

HEALTH OF WOMAN. 2017.4(120):35–40; doi 10.15574/HW.2017.120.35

Gerasimova T. V., Morozova O. V., Gopchuk Ye. N.
National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev

The data of endothelium dysfunction and its connection with pathology in sphere of obstetrics and gynecology is presented. Role of L-arginine donators in treatment of endothelium deficiency-caused diseases is observed

Key words: Tivomax, L-arginine, endothelium. Obstetrics and gynecology, placental deficiency, preeclampsia.

REFERENCES

1. Bloschinskaya IA. 2003. Funktsionalnoe sostoyanie sosudistogo endoteliya i narusheniya mikrotsirkulyatsii pri beremennosti, oslozhnennoy gestozom i vliyanie na nih normobaricheskoy gipoksiterapii. Avtoref. dis. kand. med. nauk. Tomsk:36. 2. Gorpinchenko II, Miroshnikov YaO. 2009. Erektilnaya disfunktsiya. Meditsina svіtu:85.

3. Lechenie erektilnoy disfunktsii. Pod redaktsiey professora II Gorpinchenko. K, Izd. dom «Professional». 2008:191.

4. Bikmetova ES, Trishkin AG, Artyimuk NV. 2012. Zaderzhka rosta ploda. Chastota, faktoryi riska. Mat i ditya v Kuzbasse 1:27–31.

5. Slyusar TI, Pilipenko ON, Dzhelomanova OA, Levchenko II. 2015. Izmenenie pokazateley fetoplatsentarnogo kompleksa u patsientok s zaderzhkoy vnutriutrobnogo razvitiya ploda i antenatalnyimi poteryami v anamneze. Zdorove zhenschiny 3:156–158.

6. Fedorova MV. 1997. Platsentarnaya nedostatochnost. Akusherstvo i ginekologiya 6:40–43.

7. Kovalev EV, Lazuko SS, Zanko YuV. 2015. Diagnosticheskaya znachimost opredeleniya indutsibelnoy no-sintazyi v diagnostike zaderzhki rosta ploda v tretem trimestre beremennosti. Ohrana materinstva i detstva 1:36–40.

8. Linde VA, Pogorelova TN, Drukker NA i dr. 2011. Rol argininovogo disbalansa v razvitii platsentarnoy nedostatochnosti. Akusherstvo i ginekologiya 4:26–30.

9. Guimarгes MF, Brandгo AH, Rezende CA. 2014. Assessment of endothelial function in pregnant women. Arch Gynecol Obstet. 290:441–447.

10. Bird IM, Boeldt DS, Krupp J. 2013. Pregnancy, programming and preeclampsia: gap junctions at the nexus of pregnancy-induced adaptation of endothelial function and endothelial adaptive failure in PE. Current Vascular Pharmacology 11:712–729. https://doi.org/10.2174/1570161111311050009; PMid:24063383

11. Schroeder BM. 2012. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician. 66:330–331.

12. Roberts JM, Lain KY. 2012. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 23:359–372. https://doi.org/10.1053/plac.2002.0819; PMid:12061851

13. Baschat AA. 2010. Fetal growth restriction – from observation to intervention. J. Perinat. Med. 38;3:239–246. https://doi.org/10.1515/jpm.2010.041

14. Gornik HL, Creager MA. 2004. Arginine and endothelial and vascular health. J.Nutr. 134:2880S–2887S. PMid:15465805

15. Neri I, Jasonni VM, Gori GF. 2006. Effect of L-arginine on blood pressure in pregnancy induced hypertension: a randomized placebo-controlled trial. J. Matern. Fetal Neonatal. Med. 19(5):277–281. https://doi.org/10.1080/14767050600587983; PMid:16753767

16. Savvidou MD, Hingorani AD, Tsikas D. 2003. Endothelial dysfunction and raised plasma concentrations of asymmetric dimetylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 361:1511–1517. https://doi.org/10.1016/S0140-6736(03)13177-7

Содержание журнала Full text of article